HYPOXIA AND VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION IN HUMAN SQUAMOUS-CELL CARCINOMAS USING PIMONIDAZOLE AS A HYPOXIA MARKER

Citation
Ja. Raleigh et al., HYPOXIA AND VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION IN HUMAN SQUAMOUS-CELL CARCINOMAS USING PIMONIDAZOLE AS A HYPOXIA MARKER, Cancer research, 58(17), 1998, pp. 3765-3768
Citations number
20
Categorie Soggetti
Oncology
Journal title
ISSN journal
00085472
Volume
58
Issue
17
Year of publication
1998
Pages
3765 - 3768
Database
ISI
SICI code
0008-5472(1998)58:17<3765:HAVEGE>2.0.ZU;2-7
Abstract
Hypoxia in human tumors is associated with poor prognosis, but the mol ecular mechanisms underlying this association are poorly understood. O ne possibility is that hypoxia is linked to malignant progression thro ugh vascular endothelial growth factor (VEGF) induction and the associ ated angiogenesis and metastasis, The present clinical study measures hypoxia and VEGF expression on a cell-by-cell basis in human squamous cell carcinomas to test the hypothesis that hypoxia and VEGF protein e xpression are coupled in human tumors. Eighteen patients with invasive squamous cell carcinoma of the uterine cervix and head and neck have been investigated by a quantitative image analysis of immunostained se ctions from their tumors. The hypoxia marker pimonidazole was used to measure tumor hypoxia, and a commercially available antibody was used to measure VEGF protein expression. A quantitative immunohistochemical comparison of hypoxia and VEGF protein expression revealed no correla tion between the two factors.